openPR Logo
Press release

Fibromyalgia - Drug Pipeline Landscape, 2022

01-19-2023 07:06 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: Global insight services

Fibromyalgia is a is a common chronic syndrome characterized by widespread musculoskeletal pain, fatigue, sleep, memory and cognitive issues.

Researchers reported that repeated nerve stimulation causes the brain and spinal cord of people with fibromyalgia to change. The conditions conditions that may bring on symptoms, such as: stressors, viral infections or other illnesses like arthritis, anxiety, depression, other mood disorders, PTSD.

To know more about Fibromyalgia - Drug Pipeline, visit - https://www.globalinsightservices.com/reports/fibromyalgia-drug-pipeline-landscape-2022/

Fibromyalgia can be diagnosed if the patient had widespread pain for 3 months or longer. Healthcare professionals use a process of elimination to diagnose fibromyalgia, for concluding that no other condition is causing the pain. Healthcare professionals may rule out other conditions that may have similar symptoms with some tests including complete blood count, Rheumatoid factor, thyroid function tests, anti-nuclear antibody, cyclic citrullinated peptide test etc.

Treatment of fibromyalgia includes medications such as pain relievers, antidepressants and anti-seizure drugs. therapies like physical therapy, occupational therapy and counselling can also be advised.

There are many companies that are actively developing drugs for the treatment of fibromyalgia, including Pfizer, Astellas Pharma, Tonix Pharmaceuticals, Cortene Inc etc.

Get a free sample copy of this Report - https://www.globalinsightservices.com/request-sample/GIS31036/

Report Highlights

Global Insight Service's, Fibromyalgia - Drug Pipeline Landscape, 2022 report provides an overview of the Fibromyalgia pipeline drugs. This report covers detailed insights on Fibromyalgia drugs under development, assessment by target, mechanism of action, route of administration and molecule type. Product pipeline by companies, stage of development and key regulatory designations, deals and milestones have been presented to provide insights and thus help industry participants in their decision making. Fibromyalgia pipeline report helps gain insights on drugs which are under development stage of drug development process across globally.

Scope

The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration. The report provides a review of pipeline therapeutics by companies based on information derived from company and industry-specific sources. The pipeline report covers assessment of therapeutics by mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. Comprehensive profiles of the pipeline products with details such as company overview, development stage; molecule type, target, mechanism of action, route of administration, dosage form, regulatory designations, key deals, clincial trials, and key upcoming milestones are included.

Free customization available -https://www.globalinsightservices.com/request-customization/GIS31036

Reasons to Buy

Helps to find and recognize significant therapeutics under development. Thorough understanding of pipeline structure and helps in developing corrective measures for pipeline projects.

Effective R&D strategies can be developed with deep knowledge of competitor information, analysis, and insights.

Plan collaborations with various industry partners that have role in some or the other stage of drug development such as contract manufacturing, co-development, contract research organization and commercialization etc.

Helps to create in-licensing and out-licensing opportunities by identifying prospective partners with attractive projects to expand business potential and scope.

Buy this report - https://www.globalinsightservices.com/checkout/single_user/GIS31036/

Methodology

The research process includes extensive secondary research on public domain and other authentic sources to add or update the pipeline products information. The secondary research sources include, but are not limited to company websites, annual reports, financial reports, company pipeline chart, investor presentations and SEC filings, journals and conferences, and clinical trials registries.

Contact Us:

Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700

About Global Insight Services:

Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Fibromyalgia - Drug Pipeline Landscape, 2022 here

News-ID: 2891826 • Views:

More Releases from Global insight services

Blockchain as a Service (BaaS) Market Expected to Skyrocket from $4.5 Billion in 2024 to $36.5 Billion by 2034 at 23.3% CAGR | Overall Study Report & Key Players Analysis
Blockchain as a Service (BaaS) Market Expected to Skyrocket from $4.5 Billion in …
The Blockchain as a Service (BaaS) market is experiencing remarkable growth, projected to expand from $4.5 billion in 2024 to $36.5 billion by 2034, registering a CAGR of approximately 23.3%. BaaS offers cloud-based platforms that allow businesses to develop, host, and deploy blockchain applications without having to manage complex infrastructure. This approach enables organizations to integrate blockchain functionalities such as smart contracts, secure transactions, and supply chain tracking seamlessly into
Underfloor Heating Market Expected to Reach $10.2 Billion by 2034 with a 7.2% CAGR | Key Players Analysis & Overall Study Report
Underfloor Heating Market Expected to Reach $10.2 Billion by 2034 with a 7.2% CA …
The underfloor heating market is on a promising growth trajectory, expected to expand from $5.1 billion in 2024 to $10.2 billion by 2034, reflecting an impressive CAGR of 7.2%. This market centers on the development, manufacturing, and installation of heating systems embedded beneath flooring surfaces. It includes both electric and hydronic systems that serve residential, commercial, and industrial spaces. The driving forces behind this growth include increasing demand for energy-efficient
Long Read Sequencing Market Global Industry Analysis, Demand, and Forecast to Hit $9.1 Billion by 2034, Growing at 14.3% CAGR
Long Read Sequencing Market Global Industry Analysis, Demand, and Forecast to Hi …
Market Overview Long Read Sequencing Market is experiencing a remarkable surge, redefining the way scientists and healthcare professionals approach genetic research. Unlike traditional short-read methods, long read sequencing delivers extended DNA fragments, enabling more precise insights into genome assembly, structural variations, and epigenetic studies. This technology is rapidly becoming indispensable in healthcare, agriculture, and biotechnology. With its ability to unravel complex genetic information, it is fueling advancements in personalized medicine, crop
AI Training Dataset Market Size, Share, Growth Trends, and Forecast to Reach $12.06 Billion by 2034 at 14.6% CAGR
AI Training Dataset Market Size, Share, Growth Trends, and Forecast to Reach $12 …
Market Overview AI Training Dataset Market has become the backbone of artificial intelligence development, offering the structured and annotated data required to train machine learning models effectively. Whether it's text, images, audio, or video, datasets provide the foundation upon which intelligent systems learn, adapt, and improve. From powering autonomous vehicles to enhancing natural language processing and healthcare diagnostics, these datasets ensure accuracy and efficiency in AI-driven solutions. In 2024, the market

All 5 Releases


More Releases for Fibromyalgia

Government Initiatives On Musculoskeletal Health Propel Growth In The Fibromyalg …
The Fibromyalgia Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Projected Growth of the Fibromyalgia Treatment Market? The market for the treatment of fibromyalgia has been expanding consistently in past years. At a compound annual growth rate (CAGR) of 3.9%, it is
SN Clinic's Effective Treatment of Fibromyalgia Symptoms
Image: https://www.globalnewslines.com/uploads/2025/02/1740408683.jpg SN Clinic Logo Fibromyalgia can be a debilitating condition, but SN Clinic offers hope through innovative treatments like MLS Laser Therapy and complementary massage therapies. By addressing chronic pain through a holistic approach, patients can experience significant relief and an improved quality of life. What is Fibromyalgia and What Does Current Data Say? Fibromyalgia is a chronic condition characterized by widespread musculoskeletal pain, fatigue, and tenderness in localized areas. Affecting
Prominent Fibromyalgia Treatment Market Trend for 2025: Market Leaders Focus On …
What Are the Projected Growth and Market Size Trends for the Fibromyalgia Treatment Market? The Fibromyalgia Treatment market is expected to grow from $2.79 billion in 2024 to $2.9 billion in 2025, at a CAGR of 3.9%. This growth is attributed to the increasing prevalence of fibromyalgia, greater awareness about the condition, government initiatives, and rising disposable incomes. The fibromyalgia treatment market is projected to see steady growth, reaching $3.45 billion by
Advancements in Fibromyalgia Treatments Driving Market Expansion
The fibromyalgia treatment market is experiencing a steady upward trajectory, with significant growth expected over the next decade. Estimated at USD 2.77 billion in 2023, the market is projected to reach approximately USD 4.13 billion by 2032, growing at a compound annual growth rate (CAGR) of 4.3% from 2024 to 2032. This expansion is driven by several key factors, including advances in treatment options, increasing demand for effective therapies, and
Fibromyalgia Treatment Market 2022 | Increased Morbidity of Fibromyalgia Along w …
According to Precision Business Insights (PBI), the latest report, the Fibromyalgia Treatment market is expected to be valued at USD 3,017.9 million in 2022, growing at an 3.8% CAGR from 2022 to 2028. Fibromyalgia treatment market analysis projects that the increased prevalence of fibromyalgia and its related complication compelled the introduction of targeted & precise treatment methods for fibromyalgia. Also, the increase in awareness about fibromyalgia will give the required
Fibromyalgia - Drug Pipeline Landscape, 2022
Fibromyalgia is a is a common chronic syndrome characterized by widespread musculoskeletal pain, fatigue, sleep, memory and cognitive issues. Researchers reported that repeated nerve stimulation causes the brain and spinal cord of people with fibromyalgia to change. The conditions conditions that may bring on symptoms, such as: stressors, viral infections or other illnesses like arthritis, anxiety, depression, other mood disorders, PTSD. Fibromyalgia can be diagnosed if the patient had widespread pain